Nephrology Stents And Catheters Market Size

Nephrology Stents And Catheters Market Analysis

The nephrology stents and catheters market is valued at USD 1.44 billion in 2023 and is expected to reach USD 2.03 billion by the year 2028, registering a CAGR of 7.10% over the forecast period.

COVID-19 impacted the growth of the nephrology stents and catheter market. The lockdown measures imposed by the government to avoid the spread of coronavirus among the population resulted in the shutting down of patient visits in hospitals, clinics, and dialysis centers, which has impacted the lives of patients suffering from nephrology diseases. For instance, from an article published in Frontiers in Physiology in July 2021, it has been observed that the diagnosis of various kidney diseases was delayed during the COVID-19 pandemic as non-urgent tests and visits were postponed due to the closure of medical services during the lockdown. This has affected the histological examination for kidney diagnosis in the initial days of the pandemic, impacting the demand for nephrology stents and catheters during the pandemic. However, in later times of the pandemic, with the resumption of non-essential surgical procedures, the market has started to gain traction. It is expected to continue the upward trend over the forecast period.

The increasing incidence of nephrology disorders, rising geriatric population, and technological advancement in the material used for catheters and stents are the major drivers for the market. For instance, as per the data published by the Australian Institute of Health and Welfare in August 2022, it was observed that in Aboriginal and Torres Strait Islanders, 292 males and 677 females per 100,000 population had chronic kidney diseases in 2021, respectively. As per the same source, Indigenous Australians were 4.6 times more likely to be diagnosed with chronic kidney disease than their non-Indigenous counterparts. Thus, such instances indicate that the demand for surgeries is expected to increase, which may surge the demand for nephrology stents and catheters, thereby propelling the market growth.

The strong pipeline scenario related to nephrology stents and catheters drives market growth. For instance, according to the research journal published by the Medical Device Network in January 2022, pipeline nephrology and urology products in 2021 witnessed a 75.0% rise globally compared to Nephrology and Urology pipeline products in 2020. The devices at an advanced stage of development (in clinical trials, in the approval process, already approved in Europe, or in the rest of the world) accounted for 45.65% of medical devices in 2021, compared to 37.93% in 2020. The number of devices at the approval stage in 2021 increased by 100.0% compared to 2020. Furthermore, the same source also stated that approximately 43.0% of pipeline nephrology and urology devices in 2021 were expected to receive regulatory approval by the end of 2025. The top device category expected to receive regulatory approval by the end of 2025 was urinary catheters, with 6.0% of devices. Thus, owing to increasing regulatory approvals, the demand for nephrology stents and catheters is expected to increase; thereby, considerable market growth is expected over the forecast period.

However, discomfort and pain due to stents and catheters and the risk of infection due to unclean instruments will likely restrict the market growth over the forecast period.